News-Medical.Net on MSN
Two isoforms of a cellular energy sensor play distinct, opposing roles in Alzheimer's disease
A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest ...
The hair follicle is a highly dynamic mini-organ that undergoes cyclic phases of growth, regression, and rest. The anagen ...
A review paper by scientists at Beijing Institute of Graphic Communication presented a thorough review of the existing ...
Mastiha resin from Pistacia lentiscus supports gut barrier integrity and immune modulation through antioxidant, ...
Ad hoc announcement pursuant to Art. 53 LR Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is ...
Millennial Skin on MSN
Accutane under the microscope: The real biology behind how isotretinoin rewires acne
Accutane, known generically as isotretinoin, is not simply a strong acne medication. It is a systemic retinoid that ...
Morning Overview on MSN
Scientists link 2 cancer hallmarks in a way no one expected
Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...
Discover how CJC-1295 peptide stack research has influenced CrazyBulk’s Growth Hormone Stack, designed to support recovery speed, lean muscle, and training output. Intro. New Yo ...
Newron Pharmaceuticals further expands its intellectual property portfolio for Evenamide with a new EU composition of matter ...
M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.
Ad hoc announcement pursuant to Art. 53 LR EP4615820 "Crystalline Forms of Evenamide" is expected to extend asset exclusivity in EU into 2044 Evenamide is currently being investigated in Newron's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback